Vaccination With Autologous Dendritic Cells Loaded With Autologous Tumor Lysate or Homogenate Combined With Immunomodulating Radiotherapy and/or Preleukapheresis IFN-alfa in Patients With Metastatic Melanoma: a Randomized "Proof-of-principle" Phase II Study

NCT01973322 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

34

Enrollment

OTHER

Sponsor class

Conditions

Malignant Melanoma of Skin Stage III
Malignant Melanoma of Skin Stage IV

Interventions

OTHER: arm 1: DC Vaccine + RT
OTHER: arm 2: DC Vaccine + IFN-alfa
OTHER: arm 3: both arm 1 and 2 + RT
BIOLOGICAL: arm 4: DC Vaccine

Sponsor

Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS